一个由罗菲科克西布衍生出的疗效探针及其与PD-1抑制剂的组合,用于高效的癌症治疗

Xinli Wang1, Xia Wang2, Xuejing Su2,3

  • 1Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.

Archiv der Pharmazie
|December 12, 2025
PubMed
概括

一种新的循环氧化酶-2 (COX-2) 向探针增强了瘤可视化,并实现了显著的瘤回归. 将这种探针与编程细胞死亡蛋白1 (PD-1) 抑制剂相结合,导致95%的瘤回归.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K